直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Podcast

SaMD Series: Branding Considerations

July 6, 2018

By Elizabeth D. Ferrill; Margaret A. Esquenet

Software as a Medical Device–also referred to as SaMD–is one of the fastest growing innovations in the medical device industry. As with any technology that experiences rapid adoption, challenges related to intellectual property protection often follow. In this series, we take a close look at IP considerations that SaMD developers should be aware of as they enter this market.

In this podcast, Finnegan attorneys Beth Ferrill and Margaret Esquenet explore IP challenges related to the branding of SaMDs.

Tags

software as a medical device (SaMD), branding, Podcast Series: Software as a Medical Device (SaMD)

Downloadable Files

  • FerrillEsquenet_SaMD_Branding_07-06-18

Related Practices

Trademark and Brand Management

Related Industries

Life Sciences

Medical Device and Diagnostics

Related Offices

Washington, DC

Related Professionals

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Related Insights

Conference

IP Life Sciences Forum 2026

December 13-15, 2026

Coral Gables

Conference

2026 ANA Masters of Advertising Law Conference

November 2-4, 2026

Huntington Beach

Conference

LES 2026 Annual Meeting

October 18-21, 2026

San Diego

Conference

2026 FCBA Global Series Fall Session

October 14-16, 2026

Dublin

Conference

WTR Live: Brand Strategy Summit USA 2026

October 13-14, 2026

New York

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: August 2026

September 29, 2026

Conference

2026 IPO Annual Meeting

September 27-29, 2026

Toronto

INCONTESTABLE® Blog

Finding a Lack of Bona Fide Use, TTAB Affirms Cancellation of Everwise Credit Union Registration Under the Lanham Act’s Reexamination Procedure

September 24, 2026

Virtual Seminar

2026 Fall WALA Creative Entrepreneurs Series

September 22, 2026

Virtual

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP